Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS)
- Conditions
- Non Small Cell Lung Cancer Stage IIIBNon-Small Cell Carcinoma of Lung, TNM Stage 4
- Interventions
- First Posted Date
- 2017-09-20
- Last Posted Date
- 2020-10-29
- Lead Sponsor
- Biocad
- Target Recruit Count
- 218
- Registration Number
- NCT03288870
- Locations
- 🇧🇾
Gomel Regional Clinical Oncology Dispensary, Gomel, Belarus
🇷🇺Arkhangelsk District Clinical Oncology Dispensary, Arkhangelsk, Russian Federation
🇷🇺Clinical Oncology Dispensary N1, Krasnodar, Russian Federation
International Trial of the Efficacy and Safety of BCD-100 in Patients With Melanoma
- Conditions
- Melanoma
- First Posted Date
- 2017-09-01
- Last Posted Date
- 2020-09-18
- Lead Sponsor
- Biocad
- Target Recruit Count
- 126
- Registration Number
- NCT03269565
- Locations
- 🇷🇺
State Budgetary Institution of Healthcare of the Arkhangelsk Region "Arkhangelsk Regional Clinical Oncology Dispensary" (SBHI AR ARCOD), Arkhangel'sk, Russian Federation
🇷🇺"N.N. Blokhin Russian Cancer Research Center", Moscow, Russian Federation
🇷🇺State Budgetary Healthcare Institution "Moscow Clinical Scientific Center funded by Moscow Health Department" (SBHI MCSC MHD), Moscow, Russian Federation
First-in-human Study of Safety, Pharmacokinetics and Pharmacodynamics of Various Doses of BCD-089 in Healthy Subjects
- Conditions
- Healthy
- First Posted Date
- 2017-04-06
- Last Posted Date
- 2021-02-26
- Lead Sponsor
- Biocad
- Target Recruit Count
- 19
- Registration Number
- NCT03103438
- Locations
- 🇷🇺
LLC BioEk, Saint-Petersburg, Russian Federation
First-in-human Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Doses of BCD-121 in Healthy Subjects
- First Posted Date
- 2017-04-06
- Last Posted Date
- 2017-07-17
- Lead Sponsor
- Biocad
- Target Recruit Count
- 28
- Registration Number
- NCT03103451
Study of BCD-115 in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast Cancer
- First Posted Date
- 2017-02-27
- Last Posted Date
- 2018-03-13
- Lead Sponsor
- Biocad
- Target Recruit Count
- 6
- Registration Number
- NCT03065010
- Locations
- 🇷🇺
N.N. Blokhin Russian Cancer Research Center, Sankt Petersburg, Russian Federation
A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors
- Conditions
- Lung CancerRenal Cell CarcinomaMelanoma
- First Posted Date
- 2017-02-10
- Last Posted Date
- 2018-08-31
- Lead Sponsor
- Biocad
- Target Recruit Count
- 15
- Registration Number
- NCT03050047
- Locations
- 🇷🇺
"Russian Cancer Research Center named after N.N. Blokhin "of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
🇷🇺LLC BioEk, Saint-Petersburg, Russian Federation
🇷🇺State budgetary health care institution "St. Petersburg Clinical Scientific and Practical Center of Specialized Medical Assistance (Oncological)", Sankt Petersburg, Russian Federation
Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis
- First Posted Date
- 2016-05-05
- Last Posted Date
- 2021-11-01
- Lead Sponsor
- Biocad
- Target Recruit Count
- 88
- Registration Number
- NCT02763111
Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis
- Interventions
- First Posted Date
- 2016-05-05
- Last Posted Date
- 2019-06-14
- Lead Sponsor
- Biocad
- Target Recruit Count
- 426
- Registration Number
- NCT02762838
- Locations
- 🇧🇾
Institution of Healthcare "9th Municipal Clinical Hospital", Minsk, Belarus
🇧🇾Institution of Healthcare "First Municipal Clinical Hospital", Minsk, Belarus
🇧🇾Institution of Healthcare "Ordena Trudovogo Krasnogo Znameni Regional Clinical Hospital", Minsk, Belarus
Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis
- Conditions
- Ankylosing Spondylitis
- First Posted Date
- 2016-05-05
- Last Posted Date
- 2018-02-23
- Lead Sponsor
- Biocad
- Target Recruit Count
- 199
- Registration Number
- NCT02762812
- Locations
- 🇷🇺
North-Western State Medical University n.a. I.I.Mechnikov, St.Petersburg, Russian Federation
Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis
- Conditions
- Psoriasis
- First Posted Date
- 2016-05-05
- Last Posted Date
- 2021-09-08
- Lead Sponsor
- Biocad
- Target Recruit Count
- 344
- Registration Number
- NCT02762955
- Locations
- 🇷🇺
BIOCAD, Saint Petersburg, Strelna, Russian Federation